Germany
Japan
United Kingdom
China
Antibodies
View as table Download
TGFBI Goat Polyclonal (Internal) Antibody
| Applications | IHC |
| Reactivities | Bat, Gibbon, Bovine, Dog, Gorilla, Horse, Human, Mouse, Pig, Rabbit, Rat |
| Conjugation | Unconjugated |
| Immunogen | TGFBI antibody was raised against synthetic peptide C-QLYTDRTEKLRPE from an internal region of human TGFBI (NP_000349.1). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey, Mouse, Rat, Elephant, Panda, Bovine, Dog, Bat, Horse, Rabbit, Pig, Opossum (100%); Marmoset, Platypus (92%). |
Rabbit Polyclonal CTRP3 Antibody
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
| Immunogen | CTRP3 antibody was raised against a 16 amino acid synthetic peptide from near the center of human CTRP3. The immunogen is located within amino acids 90 - 140 of CTRP3. |
Rabbit polyclonal PEK/PERK (Thr981) antibody(Phospho-specific)
| Applications | IHC |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human PEK/PERK around the phosphorylation site of threonine 981 (R-H-TP-G-Q). |
| Modifications | Phospho-specific |
Rabbit Polyclonal Antibody against LOX
| Applications | IHC, WB |
| Reactivities | Human, Mouse, Rat, Porcine, Cow |
| Conjugation | Unconjugated |
| Immunogen | A cocktail of two synthetic peptides; one made to a region of the human LOX protein within residues 300-400 and one within residues 200-300 |
Rabbit Polyclonal Antibody against WIF1 (N-term)
| Applications | IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
| Immunogen | This WIF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 51-80 amino acids from the N-terminal region of human WIF1. |
Active filters
Category
- Antibodies
Reactivities
- Mouse
Applications
- IHC
Conjugates
- Unconjugated
Families
- Secreted Protein
Availabilities
- In Stock
Filter by
Target Symbol
- LGALS3 (33)
- F13A1 (21)
- AGR2 (19)
- SYP (19)
- EGFR (15)
- LOX (15)
- SYT4 (13)
- FGFR2 (11)
- ERBB3 (9)
- FN1 (9)
- TIMP2 (9)
- WNT3 (9)
- FGG (8)
- NTF3 (8)
- CPA2 (6)
- LOXL2 (5)
- POSTN (5)
- SIL1 (5)
- ANGPT1 (4)
- BMP4 (4)
- CHGA (4)
- GCG (4)
- IGF1 (4)
- NOG (4)
- NTF4 (4)
- SERPINE2 (4)
- SFRP2 (4)
- VEGFB (4)
- ADM (3)
- AFP (3)
- AGT (3)
- ANGPTL1 (3)
- BMP3 (3)
- DEFA1 (3)
- DPP4 (3)
- EIF2AK3 (3)
- FGF2 (3)
- GNAS (3)
- MUC1 (3)
- RNPEP (3)
- RSPO1 (3)
- RSPO3 (3)
- TGFBI (3)
- TNFSF13 (3)
- VEGFC (3)
- ACE2 (2)
- ADAMTS4 (2)
- ADAMTSL1 (2)
- ADCK1 (2)
- AGR3 (2)
- AGRP (2)
- AMH (2)
- AMPH (2)
- AMY2B (2)
- ANGPT2 (2)
- ANGPTL4 (2)
- ANXA2 (2)
- APOA1 (2)
- APOH (2)
- ARSK (2)
- BDNF (2)
- BPIFB2 (2)
- CANT1 (2)
- CCL17 (2)
- COX16 (2)
- CRP (2)
- DCN (2)
- ECRG4 (2)
- EDA (2)
- FAM3A (2)
- FBLN1 (2)
- FGF13 (2)
- FGF7 (2)
- GABBR1 (2)
- GAS6 (2)
- GSN (2)
- IGFBP7 (2)
- IL17B (2)
- IL20 (2)
- INHA (2)
- LAIR2 (2)
- LAMA3 (2)
- LAMB2 (2)
- MMP19 (2)
- NRG1 (2)
- PRL (2)
- PSPN (2)
- PTHLH (2)
- RAB37 (2)
- RETN (2)
- RETNLB (2)
- SCG3 (2)
- SCT (2)
- SERPINA1 (2)
- SERPINC1 (2)
- SFRP1 (2)
- SFTPD (2)
- SHBG (2)
- SHH (2)
- SPATA6 (2)
Antibody Hosts
Isotypes
Clonalities
Knockout (KO) Validation
Modifications
Pathways
- Pathways in cancer (101)
- Cytokine-cytokine receptor interaction (68)
- MAPK signaling pathway (62)
- Regulation of actin cytoskeleton (54)
- Focal adhesion (49)
- Complement and coagulation cascades (41)
- Endocytosis (36)
- Melanoma (34)
- Prostate cancer (33)
- Wnt signaling pathway (28)
- Calcium signaling pathway (27)
- ErbB signaling pathway (27)
- Pancreatic cancer (26)
- Bladder cancer (25)
- Basal cell carcinoma (24)
- Hedgehog signaling pathway (24)
- ECM-receptor interaction (21)
- Melanogenesis (21)
- Glioma (20)
- GnRH signaling pathway (19)
- TGF-beta signaling pathway (19)
- Gap junction (18)
- Colorectal cancer (16)
- Neurotrophin signaling pathway (16)
- Non-small cell lung cancer (16)
- Small cell lung cancer (16)
- Adherens junction (15)
- Dorso-ventral axis formation (15)
- Endometrial cancer (15)
- Epithelial cell signaling in Helicobacter pylori infection (15)
- Jak-STAT signaling pathway (15)
- mTOR signaling pathway (14)
- Renal cell carcinoma (11)
- Dilated cardiomyopathy (10)
- Neuroactive ligand-receptor interaction (9)
- Adipocytokine signaling pathway (8)
- Chemokine signaling pathway (8)
- Hematopoietic cell lineage (8)
- Hypertrophic cardiomyopathy (HCM) (8)
- Long-term depression (8)
- Toll-like receptor signaling pathway (8)
- Alzheimer's disease (7)
- Metabolic pathways (7)
- PPAR signaling pathway (7)
- p53 signaling pathway (7)
- Apoptosis (6)
- Renin-angiotensin system (6)
- NOD-like receptor signaling pathway (5)
- Natural killer cell mediated cytotoxicity (5)
- Oocyte meiosis (5)
- Progesterone-mediated oocyte maturation (5)
- Type I diabetes mellitus (5)
- Allograft rejection (4)
- Antigen processing and presentation (4)
- Autoimmune thyroid disease (4)
- Fc gamma R-mediated phagocytosis (4)
- Graft-versus-host disease (4)
- RIG-I-like receptor signaling pathway (4)
- Type II diabetes mellitus (4)
- Amyotrophic lateral sclerosis (ALS) (3)
- Asthma (3)
- Axon guidance (3)
- Cytosolic DNA-sensing pathway (3)
- Regulation of autophagy (3)
- SNARE interactions in vesicular transport (3)
- Starch and sucrose metabolism (3)
- Systemic lupus erythematosus (3)
- Taste transduction (3)
- Vascular smooth muscle contraction (3)
- Vibrio cholerae infection (3)
- Fc epsilon RI signaling pathway (2)
- Huntington's disease (2)
- Maturity onset diabetes of the young (2)
- Purine metabolism (2)
- Pyrimidine metabolism (2)
- T cell receptor signaling pathway (2)
- VEGF signaling pathway (2)
- Cell adhesion molecules (CAMs) (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Glycerolipid metabolism (1)
- Histidine metabolism (1)
- Insulin signaling pathway (1)
- N-Glycan biosynthesis (1)
- Pathogenic Escherichia coli infection (1)
- Primary immunodeficiency (1)
- Prion diseases (1)
- Viral myocarditis (1)
- beta-Alanine metabolism (1)